Optimi Health Secures Certification for 40mg and 60mg MDMA GMP Capsules | CSE:OPTI, OTCQB:OPTHF

Proactive InvestorsMay 15 06:29 ET

Optimi Health Corp. Expands Global Reach With MDMA Export

TipRanksMay 9 09:07 ET

Early Warning Press Release in Accordance With National Instrument 62-103

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each a "Common Share") of Optimi Health Corp. (the "Iss

newsfileApr 4 08:55 ET

Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University

Optimi Health Corp. (OPTI.CN), specializing in controlled substances such as natural psilocybin and MDMA, has entered into an international MDMA supply agreement with The Institute for Psychedelic Res

MT NewswiresMar 26 08:01 ET

Optimi Health Granted Precursor Licence to Formulate MDMA, Completes Encapsulation Of Two Dosage Formats

Optimi Health Corp. (OPTI.CSE) a licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces that it has been granted its P

MT NewswiresJan 3 11:56 ET

Optimi Health Says Achieved Genetics Milestone and Completed Psilocybin Extract Validation and Stability Testing

Optimi Health Corp. (OPTI.CSE) on Tuesday reports that it has achieved a significant milestone. The company has harvested eight new natural psilocybin genetics. Optimi cultivated these [pilocybin-cont

MT NewswiresNov 28, 2023 10:49 ET